DOWN-REGULATED EXPRESSION OF PTEN GENE AND LOH OF ITS EPIGENETIC MICROSATELLITES IN GASTRIC CARCINOMA
Chinese Medical Sciences JournalVol. 0, Issue 4, Pages: 237-242(2003)
Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
DOWN-REGULATED EXPRESSION OF PTEN GENE AND LOH OF ITS EPIGENETIC MICROSATELLITES IN GASTRIC CARCINOMA
Affiliations:
1. Li Jinyi 1 ,Zheng Huachuan 2 ,Xu Lei 2 ,Yang Xuefei 2 ,Gao Hong 3 and Xin Yan 2, 1 Armed Police General Hospital,Beijing100012 2 The 4th Laboratory,Cancer Institute,The First Affiliated Hospital of China Medical University,Shenyang110001 3 Laboratory of Pediatric Congenital Abnormality,The Second Affiliated Hospital of China Medical University,Shenyang,110004
2. ,China
3. The 4th Laboratory
4. Cancer Institute
5. The First Affiliated Hospital of China Medical University
6. Laboratory of Pediatric Congenital Abnormality
7. The Second Affiliated Hospital of China Medical University
DOWN-REGULATED EXPRESSION OF PTEN GENE AND LOH OF ITS EPIGENETIC MICROSATELLITES IN GASTRIC CARCINOMA[J]. Chinese medical sciences journal, 2003, 0(4): 237-242.
DOI:
DOWN-REGULATED EXPRESSION OF PTEN GENE AND LOH OF ITS EPIGENETIC MICROSATELLITES IN GASTRIC CARCINOMA[J]. Chinese medical sciences journal, 2003, 0(4): 237-242.DOI:
DOWN-REGULATED EXPRESSION OF PTEN GENE AND LOH OF ITS EPIGENETIC MICROSATELLITES IN GASTRIC CARCINOMA
摘要
Abstract
Objective.To investigate PTEN expression and loss of heterozygosity(LOH)of its epigenetic microsatel-lites in gastric carcinoma and explore their roles in tumorigenesis and progression of gastric carcinoma.Methods.LOH of epigenetic microsatellites of PTEN(D10S541
D10S583and D10S1687)was exam-ined in advanced gastric carcinomas(n=56)by PCR-SSCP.The mRNA and protein expressions of PTEN gene were evaluated in normal mucosa(n=56)
early(n=11)and advanced carcinomas(n=56)of the stomach using RT?PCR and immunohistochemoistry respectively.PTEN mRNA and protein expressions were compared with clinicopathological staging and lymph node metastasis of tumors.The relationship be-tween PTEN mRNA expression and LOH of microsatellites was discussed
as well as relationship between PTEN mRNA and protein expression.Results.LOH of D10S541
D10S583and D10S1687was found in28.6%(16/56)of advanced gas-tric carcinomas.The positive rates of PTEN expression were80.4%(45/56)
45.5%(5/11)and32.1%(18/56)in normal gastric mucosa
early and advanced gastric carcinomas at mRNA level
while78.6%(44/56)
36.4%(4/11)and28.6%(16/56)at protein level.PTEN mRNA and protein were less fre-quently expressed in early and advanced gastric carcinomas than normal gastric mucosa(P<0.05).There was negative correlation between PTEN mRNA expression and LOH of microsatellites(P<0.05).PTEN protein expression paralleled to its mRNA expression(P<0.05).The PTEN mRNA and protein expres-sions were negatively correlated with lymph node metastasis of advanced gastric carcinomas(P<0.05).Conclusion.Down?regulated expression of PTEN and frequent LOH of its epigenetic microsatellites might play an important role in gastric carcinogenesis.Reduced PTEN mRNA expression was closely as-sociated with LOH of its epigenetic microsatellites.Altered expression of PTEN might contribute to lymph node metastasis of gastric carcinoma by decreasing cell adhesion and apoptosis
POTENTIATION OF DOCETAXEL ANTITUMOR ACTIVITY BY BATIMASTAT AGAINST MOUSE FORESTOMACH CARCINOMA
EFFECTS OF MUTATION AND EXPRESSION OF PTEN GENEmRNA ON TUMORIGENESIS AND PROGRESSION OFEPITHELIAL OVARIAN CANCER
EXPRESSION OF PTEN AND CASPASE-3 AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE IN PRIMARY GASTRIC MALIGNANT LYMPHOMA
EXPRESSION OF MASPIN AND KAI1 AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE IN CARCINOGENESIS AND PROGRESSION OF GASTRIC CANCER
Clinicopathological features of non-familial colorectal cancer with high-frequency microsatellite instability
Related Author
Peng Jin
Xiao-ming Meng
Jian-qiu Sheng
Zi-tao Wu
Lei Fu
He-juan An
Ying Han and Shi-rong Li
Ying-hui Zhang
Related Institution
Chen Ying2,Zheng Huachuan1,Yang Xuefei1,Sun Limei2,and Xin Yan1*1The Fourth Laboratory, Cancer Institute, the First Affiliated Hospital ofChina Medical University, Shenyang 1100012Shenyang Hospital of Obstetrics and Gynecology
The Fourth Laboratory
the First Affiliated Hospital ofChina Medical University Shenyang
Sun Hongwei2,Zheng Huachuan1,Yang Xuefei1,Wu Dongying1,Zhang Sumin1,Kuang Lige1,and Xin Yan1*1The Fourth Laboratory, Cancer Institute, the First Affiliated Hospital ofChina Medical University, Shenyang 1100012Department of Internal Medicine, Liaoning Tumor Hospital